{"organizations": [], "uuid": "121c208ff58bdaaf53487b1d6fa2796d54b9c074", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/3", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/22/globe-newswire-cytori-to-webcast-fourth-quarter-financial-results-on-march-8th.html", "country": "US", "domain_rank": 767, "title": "Cytori to Webcast Fourth Quarter Financial Results on March 8th", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T00:15:00.000+02:00", "replies_count": 0, "uuid": "121c208ff58bdaaf53487b1d6fa2796d54b9c074"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/22/globe-newswire-cytori-to-webcast-fourth-quarter-financial-results-on-march-8th.html", "ord_in_thread": 0, "title": "Cytori to Webcast Fourth Quarter Financial Results on March 8th", "locations": [], "entities": {"persons": [{"name": "cytori", "sentiment": "none"}], "locations": [{"name": "san diego", "sentiment": "none"}], "organizations": [{"name": "cytori therapeutics, inc.", "sentiment": "neutral"}, {"name": "cytori therapeutics, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its fourth quarter financial results and business update on Thursday, March 8, 2018 at 5:30 PM Eastern Time.\nThe dial-in information is as follows: Dial-In Number: +1.877.402.3914 Conference ID: 9689618 Prior to the webcast at approximately 4:30 PM Eastern Time on March 8 th , Cytori will issue its fourth quarter earnings release which will review Cytori’s fourth quarter and annual performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.\nAbout Cytori Therapeutics, Inc.\nCytori is a therapeutics company developing regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. Cytori Nanomedicine™ is developing liposome encapsulated therapies for regenerative medicine and oncologic indications. For more information, visit www.cytori.com .\nCytori Therapeutics, Inc.\nTiago Girao, 1.858.458.0900\nir@cytori.com\nSource:Cytori Therapeutics Inc", "external_links": ["https://www.globenewswire.com/Tracker?data=sLbDU0wXVc6mKCoJK9l-famphMcn25GcHZtX6wZ8nQBvvAqWNNsHXiau7_exgRiHj6MtZLhoIAPlpyftrTCbzD3rCD0EqKrBc0ayvX7FKMTyE7Oh-viCG-8JfE8w1oCwIiw7gRQjylUE4qgbq5O0NTgalc46YgvKqZM5JKIptk6kHGZQN53S5pVXinhfwVRENnss8eE5Ij_4T1Upa-Rnbjh5IS_6FhcwfZoYa6UWUbKSHQzdzbLXzVFLyddRnj3IU0JIREkN9ExZ_Kn_rqi5v_9aVZylymlkt2AvJwiCts4lbJvxHic6_ood3YQQ5j2VD0mepNoX6O81ff6WQ9oiiffNMuKY6XLAlDMGROWj5gn3h_6uTaHXDJpSsXUO3pqqZrOOnI9PD0oOjarG6_1vbKrL2kkO2_uBQNJAY5hs_G2X4e6UMlXZoEXgGIEjmGE3f4QUKEpWflCFSWtpN4UEElxkDKNc0F_LsPFFjQO"], "published": "2018-02-23T00:15:00.000+02:00", "crawled": "2018-02-23T01:06:09.013+02:00", "highlightTitle": ""}